Dr. Robert is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8503 Arlington Blvd
Ste 400
Fairfax, VA 22031Phone(703) 280-5390
Fax(703) 280-9596- Is this information wrong?
Education & Training
- Dana-Farber Cancer InstituteFellowship, Medical Oncology, 1980 - 1981
Brigham and Women's HospitalFellowship, Hematology, 1979 - 1980
Massachusetts General HospitalResidency, Anatomic and Clinical Pathology, 1976 - 1978
McGill University Faculty of MedicineClass of 1974
Certifications & Licensure
VA State Medical License 1991 - 2020- American Board of Pathology Anatomic Pathology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Top Doctors:Washington-Baltimore Castle Connolly, 2012
- Join now to see all
Clinical Trials
- A Phase 3, Open-Label, Randomized, Parallel, 2-Arm, Multi-Center Study of BMN 673 Versus Physician's Choice in Germline BRCA Mutation Subjects With Locally Advanced and/or Metastatic Breast Cancer, Who Have Received No More Than 2 Prior Chemotherapy Regim Start of enrollment: 2013 Oct 01Seneviratne, L.C.,Mahtani, R.L.,Kakarala, M.,McIntyre, K.J.,Hurvitz, S.A.,Byeff, P.D.,Henry, N.L.,Blum, J.L.,Eisenberg, P.D.,Diab, S.,Mina, L.A.,Yardley, D.A.,Danso, M.A.,Lindquist, D.L.,Fehrenbacher, L.,...
- A Pilot Study Utilizing Proteomic and Genomic Profiling by Reverse Phase Protein Microarray (RPMA), IHC Analysis, RNA Seq, and Exome Sequencing of Patients' Tumors to Find Potential Targets and Select Treatments for Patients With Metastatic Breast Cancer Start of enrollment: 2013 Aug 01Jahanzeb, M.,Northfelt, D.W.,Anthony, S.P.,Robert, N.J.,Payne, J.E.
- Combination Immunotherapy With Herceptin and the HER2 Vaccine E75 in Low and Intermediate HER2-expressing Breast Cancer Patients to Prevent Recurrence Start of enrollment: 2013 Jan 01Jarrod P. Holmes, MD, Lisa McGrail, MD, Michelle Miyashiro, MD, Thomas Reid, III, MD, PhD, Mahsa Mohebtash, MD, Mahsa Mohebtash, MD, Nathalie Johnson, MD, Adam Berger, MD, Tiffany Avery, MD, Rebecca Jaslo...
- PRESENT: Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer With Low to Intermediate HER2 Expressions With NeuVax™Treatment Start of enrollment: 2011 Nov 01Kenneth Deck, MD, William Audeh, MD, Andrea Stebel, MD, Richard Schwab, MD, Virginia Borges, MD, Suprith Badarinath, MD, Nikita Shah, MD, Elizabeth Tan-Chiu, MD, Hatem Soliman, MD, Jacqueline S. Jeruss, M...
- Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) Start of enrollment: 2009 Dec 01Steele, B.L.,Gallimore, H.S.,Edmiston, K.,Edmiston, K.H.,Wilkinson, M.,Robert, N.,McAuliffe, P.
- Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer Start of enrollment: 2009 Sep 01Pharmaceuticals, N., Pharmaceuticlas, N., Khong, H., Shtivelband, M., Beck, T., Patel, R., Bosserman, L., Hurvitz, S., Rundall, F., Hu, E., Davidson, S.J., McIntyre, R., Chan, D., Palmer, M., Paul, D., Me...
- A Phase III Randomized Double Blind Study of Letrozole Versus Placebo in Women With Primary Breast Cancer Completing Five or More Years of Adjuvant Tamoxifen Start of enrollment: 1998 Aug 01Castiglione-Gertsch, M.,Goss, P.E.,Ingle, J.N.,Martino, S.,Muss, H.B.,Piccart-Gebhart, M.J.,Robert, N.J.
Publications & Presentations
PubMed
- PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.Stephen Chia, Miguel Martin, Frankie Ann Holmes, Bent Ejlertsen, Suzette Delaloge, Beverly Moy, Hiroji Iwata, Gunter von Minckwitz, Janine Mansi, Carlos H. Barrios, Mi...> ;Breast Cancer Research. 2019 Mar 11
- Assessment of ERBB2 / HER2 Status in HER2 -Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP GuidelinesMichael F. Press, Jose A. Seoane, Christina Curtis, E. Quinaux, Roberta Guzman, Guido Sauter, Wolfgang Eiermann, John R. Mackey, Nicholas J. Robert, Tadeusz Pienkowski...> ;JAMA Oncology. 2019 Mar 1
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer.Joanne L. Blum, Nicholas J. Robert, Jay Andersen, Anne Favret, Patrick J. Ward, Cynthia Osborne, John Pippen> ;Journal of Clinical Oncology. 2017 Dec 11
- Join now to see all
Press Mentions
Investigators from the US Oncology Network, US Oncology Research and McKesson Present More Than 60 Research Abstracts During the 2019 American Society of Clinical Oncology Annual MeetingMay 31, 2019 00:43- Real-World Evidence from McKesson Supports First-Ever FDA Approval for Metastatic Merkel Cell Carcinoma DrugMay 16, 2018 18:12
McKesson Specialty Health and the US Oncology Network Invited to Participate in the FinalJanuary 12, 2017 11:06- Join now to see all
Hospital Affiliations
Inova Alexandria HospitalAlexandria, Virginia
Inova Fair Oaks HospitalFairfax, Virginia
Inova Fairfax HospitalFalls Church, Virginia
Novant Health UVA Health System Prince William Medical CenterManassas, Virginia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
